See up to 3 months of GMED. The 7-day demo opens the 1M and 3M ranges and puts GMED on your watchlist.
Start 7-day demoLatest GMED insider trades
About GLOBUS MEDICAL INC (GMED)
GLOBUS MEDICAL INC files with the SEC under CIK 0001237831 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
GMED Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 55,000 | $4.41M |
| Option exercise | 6 | 110,000 | |
| Bona-fide gift | 1 | 2,500 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
GMED insider transactions (Form 4)
6142 Form 4 filings on record, the earliest from Oct 18, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James R. Tobin - Director | Option exercise | Class A Common Stock | 15,000 | $53.75 | $806K | |
| James R. Tobin - Director | Option exercise | Class A Common Stock | 15,000 | $63.68 | $955K | |
| James R. Tobin - Director | Open-market sale | Class A Common Stock | 30,000 | $74.58 footnote F1 | $2.24M | |
| James R. Tobin - Director | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| James R. Tobin - Director | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| ||||||
| Stephen T. Zarrilli - Director | Option exercise | Class A Common Stock | 25,000 | $53.27 | $1.33M | |
| Stephen T. Zarrilli - Director | Open-market sale | Class A Common Stock | 25,000 | $87.04 footnote F1 | $2.18M | |
| Stephen T. Zarrilli - Director | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | - | |
| ||||||
| David D. Davidar - Director | Gift | Class A Common Stock | 2,500 | $0.00 | - | |
| David D. Davidar | Option exercise | Class A Common Stock | 25,000 | $26.27 | $657K | |
| David D. Davidar | Open-market sale | Class A Common Stock | 25,000 | $80.76 footnote F1 | $2.02M | |
| David D. Davidar | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | - | |
| ||||||
 Ann D. Rhoads | Option exercise | Class A Common Stock | 25,000 | $26.27 | $657K | |
| Ann D. Rhoads | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | - | |
| Kelly Huller - Officer | Option exercise | Class A Common Stock | 20,000 | $43.58 | $872K | |
| Kelly Huller - Officer | Open-market sale | Class A Common Stock | 20,000 | $94.50 | $1.89M | |
| Kelly Huller - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 20,000 | $0.00 | - | |
| Kelly Huller - Officer | Option exercise | Class A Common Stock | 10,000 | $45.64 | $456K | |
| Kelly Huller - Officer | Open-market sale | Class A Common Stock | 10,000 | $87.67 | $877K | |
| Kelly Huller - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 10,000 | $0.00 | - | |
| Leslie V. Norwalk | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
 Keith W. Pfeil - Officer | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 100,000 | $0.00 | - | |
| Kyle Kline - Officer | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 30,000 | $0.00 | - | |
| David C. Paul - Officer | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 100,000 | $0.00 | - | |
 Robert Andrew Douglas | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| Dan Lemaitre | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| Ann D. Rhoads | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| Stephen T. Zarrilli | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| John A. Deford | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| Dan Wolterman | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| David D. Davidar | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 15,000 | $0.00 | - | |
| Kelly Huller - Officer | Grant or award | Stock Option (Right to Buy Class A Common Stock) | 40,000 | $0.00 | - | |
| Kyle Kline - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 4,896 | $0.00 | - | |
| Kyle Kline - Officer | Option exercise | Class A Common Stock | 3,594 | $51.87 | $186K | |
| Kyle Kline - Officer | Open-market sale | Class A Common Stock | 3,594 | $101.10 | $363K | |
| Kyle Kline - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 3,594 | $0.00 | - | |
| Leslie V. Norwalk | Open-market sale | Class A Common Stock | 2,000 | $101.10 | $202K | |
| David D. Davidar | Gift | Class A Common Stock | 6,100 | $0.00 | - | |
| Leslie V. Norwalk | Open-market sale | Class A Common Stock | 4,000 | $88.85 | $355K | |
| David C. Paul - Officer | Option exercise | Class A Common Stock | 34,375 | $25.52 | $877K | |
| David C. Paul - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 34,375 | $0.00 | - | |
| Kyle Kline - Officer | Option exercise | Class A Common Stock | 3,646 | $53.14 | $194K | |
| Kyle Kline - Officer | Option exercise | Class A Common Stock | 5,000 | $56.43 | $282K | |
| Kyle Kline - Officer | Option exercise | Class A Common Stock | 5,000 | $64.44 | $322K | |
| Kyle Kline - Officer | Option exercise | Class A Common Stock | 4,896 | $63.68 | $312K | |
| Kyle Kline - Officer | Open-market sale | Class A Common Stock | 18,542 | $90.00 | $1.67M | |
| Kyle Kline - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 3,646 | $0.00 | - | |
| Kyle Kline - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 5,000 | $0.00 | - | |
| Kyle Kline - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 5,000 | $0.00 | - | |
| Kyle Kline - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 5,000 | $0.00 | - | |
| Kelly Huller - Officer | Option exercise | Class A Common Stock | 7,500 | $25.96 | $195K | |
| Kelly Huller - Officer | Open-market sale | Class A Common Stock | 7,500 | $90.00 | $675K | |
| Kelly Huller - Officer | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 7,500 | $0.00 | - | |
| David D. Davidar | Option exercise | Class A Common Stock | 25,000 | $25.52 | $638K | |
| David D. Davidar | Open-market sale | Class A Common Stock | 25,000 | $86.00 footnote F1 | $2.15M | |
| David D. Davidar | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | - | |
| ||||||
| Stephen T. Zarrilli | Option exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | - | |
| Stephen T. Zarrilli | Option exercise | Class A Common Stock | 25,000 | $44.14 | $1.10M | |
| Stephen T. Zarrilli | Open-market sale | Class A Common Stock | 25,000 | $84.29 footnote F1 | $2.11M | |
| ||||||
| Ann D. Rhoads | Open-market sale | Class A Common Stock | 8,000 | $81.00 | $648K | |
| Ann D. Rhoads | Open-market sale | Class A Common Stock | 2,000 | $85.00 | $170K | |
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Item 5.02, 7.01, 9.01
Recent GMED Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| TOBIN JAMES R | Director | 30,000 | $2.24M | View on EDGAR | |
| ZARRILLI STEPHEN T | Director | 25,000 | $2.18M |
Stock trades in GMED disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
GMED insider trading FAQ
What is the latest insider trade for GMED?
GLOBUS MEDICAL INC (GMED) had 3 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for GMED runs to 42 Form 4 filings, the earliest from 2024-10-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GMED stock?
No insider purchases of GMED were filed in the last 90 days.
How many insiders are selling GMED stock?
2 insider sales of GMED were filed in the last 90 days, totaling $4.41M.
Where can I see GMED SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GMED Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - James R. Tobin view on EDGAR
- - Stephen T. Zarrilli view on EDGAR
- - David D. Davidar view on EDGAR
- - David D. Davidar view on EDGAR
- - Ann D. Rhoads view on EDGAR
- - Kelly Huller view on EDGAR
- - Kelly Huller view on EDGAR
- - Leslie V. Norwalk view on EDGAR
- - Keith W. Pfeil view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where GMED's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GMED with a 7-day demo
- GMED on your watchlist
- Every GMED Form 4 filing on record
- Up to 3 months of GMED price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
